- Nucleic Acid Amplification
- Rapid Test
- Real-Time PCR
- Fluorescence Assay
- Western Blot
Global Blood Transfusion Diagnostics Market was valued at $4.49 billion in 2021 and is anticipated to grow at $7.09 billion till 2028 recording a CAGR of 7.1% during the forecast period 2022-2028. Blood transfusion is a medical procedure in which the blood is donated to the patient through a narrow tube that is placed within the vein. The blood transfusion is a life-saving procedure which helps in replacing the blood loss during surgery or injury. The transfusion process is done even if the patientâ€™s body is not capable of make blood owing to illness. With blood transfusion process, blood products like red blood cells, white blood cells, platelets and others are transfused to the patient. The blood transfusion diagnostics play a vital role in the blood transfusion which reduces the chance of infection. In June 2017, Grifols has launched Erytra Eflexis, the latest advancement in scalable blood typing solutions which can adapt to different laboratory workflow. Blood transfusion is the intravenous transfer of blood or blood products. Blood transfusions can be used to replace blood components that have been lost. The most common blood components transfused include red blood cells, white blood cells, platelets, clotting factors, and plasma. During an emergency or a serious case of massive blood loss, these blood components are crucial to laboratories and hospitals. When haemoglobin levels fall below 100g/L, RBC transfusion is required. Before being transfused, blood from a donor must be checked for a variety of infectious diseases. As a result, blood transfusion diagnostics play a vital role in preventing infection in both the recipient and the healthcare workers.
Fastest Growing Market
The development in the technology is a key factor attributing to the growth of the blood transfusion diagnostics market. The growing blood transfusion procedures and increasing prevalence of infectious diseases are anticipated to drive the growth of the market. Increase in the awareness among the healthcare fraternity regarding the blood transfusion is likely to propel the growth of the market. The automation of the blood banks are adding fuel for the growth of the blood transfusion diagnostics market. However, the risk involved in the transmission of the infectious diseases is likely to hinder the growth of the blood transfusion diagnostics market.
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.